{"?xml":{"@version":"1.0"},"edm:RDF":{"@xmlns:dc":"http://purl.org/dc/elements/1.1/","@xmlns:edm":"http://www.europeana.eu/schemas/edm/","@xmlns:wgs84_pos":"http://www.w3.org/2003/01/geo/wgs84_pos","@xmlns:foaf":"http://xmlns.com/foaf/0.1/","@xmlns:rdaGr2":"http://rdvocab.info/ElementsGr2","@xmlns:oai":"http://www.openarchives.org/OAI/2.0/","@xmlns:owl":"http://www.w3.org/2002/07/owl#","@xmlns:rdf":"http://www.w3.org/1999/02/22-rdf-syntax-ns#","@xmlns:ore":"http://www.openarchives.org/ore/terms/","@xmlns:skos":"http://www.w3.org/2004/02/skos/core#","@xmlns:dcterms":"http://purl.org/dc/terms/","edm:WebResource":[{"@rdf:about":"http://www.dlib.si/stream/URN:NBN:SI:DOC-04QM1G3D/56154ad0-99f0-44f9-9bb7-ccbd01e95ecf/PDF","dcterms:extent":"254 KB"},{"@rdf:about":"http://www.dlib.si/stream/URN:NBN:SI:DOC-04QM1G3D/7ee7ecd0-956a-4d26-94a4-9ed9cb411baa/TEXT","dcterms:extent":"46 KB"}],"edm:TimeSpan":{"@rdf:about":"1994-2025","edm:begin":{"@xml:lang":"en","#text":"1994"},"edm:end":{"@xml:lang":"en","#text":"2025"}},"edm:ProvidedCHO":{"@rdf:about":"URN:NBN:SI:DOC-04QM1G3D","dcterms:isPartOf":[{"@rdf:resource":"https://www.dlib.si/details/URN:NBN:SI:spr-46R7GGHL"},{"@xml:lang":"sl","#text":"Medicinski razgledi"}],"dcterms:issued":"2012","dc:creator":["Kelc, Robi","Topolovec, Janja"],"dc:format":[{"@xml:lang":"sl","#text":"številka:2"},{"@xml:lang":"sl","#text":"letnik:51"},{"@xml:lang":"sl","#text":"str. 145-157"}],"dc:identifier":["ISSN:0025-8121","COBISSID:4351551","URN:URN:NBN:SI:doc-04QM1G3D"],"dc:language":"sl","dc:publisher":{"@xml:lang":"sl","#text":"Medicinski razgledi"},"dc:subject":[{"@xml:lang":"en","#text":"Antibodies, Monoclonal"},{"@xml:lang":"en","#text":"biological drugs"},{"@xml:lang":"sl","#text":"biološka zdravila"},{"@xml:lang":"en","#text":"inflammatory mediators"},{"@xml:lang":"sl","#text":"Monoklonska protitelesa"},{"@xml:lang":"en","#text":"Neoplasms"},{"@xml:lang":"sl","#text":"Novotvorbe"},{"@xml:lang":"en","#text":"signal molecules"},{"@xml:lang":"sl","#text":"signalne molekule"},{"@xml:lang":"sl","#text":"tarčni proteini"},{"@xml:lang":"en","#text":"target proteins"},{"@xml:lang":"en","#text":"Therapy"},{"@xml:lang":"en","#text":"tumor"},{"@xml:lang":"sl","#text":"vnetni mediatorji"},{"@xml:lang":"sl","#text":"Zdravljenje"},{"@rdf:resource":"http://www.wikidata.org/entity/Q422248"}],"dcterms:temporal":{"@rdf:resource":"1994-2025"},"dc:title":{"@xml:lang":"sl","#text":"Trendi uporabe in razvoja bioloških zdravil za zdravljenje malignih obolenj| Trends of usage and development of biological drugs for treatment of malignancies|"},"dc:description":{"@xml:lang":"sl","#text":"Medicinski razgledi so recenzirana strokovna revija, ki izhaja štirikrat letno. V reviji so objavljeni raziskovalni in strokovni članki ter klinični primeri iz prakse. Revija je prvič izšla leta 1962. Ima prilogo Medicinski razgledi. Supplement. Revijo izdaja Društvo Medicinski razgledi"},"edm:type":"TEXT","dc:type":[{"@xml:lang":"sl","#text":"znanstveno časopisje"},{"@xml:lang":"en","#text":"journals"},{"@rdf:resource":"http://www.wikidata.org/entity/Q361785"}]},"ore:Aggregation":{"@rdf:about":"http://www.dlib.si/?URN=URN:NBN:SI:DOC-04QM1G3D","edm:aggregatedCHO":{"@rdf:resource":"URN:NBN:SI:DOC-04QM1G3D"},"edm:isShownBy":{"@rdf:resource":"http://www.dlib.si/stream/URN:NBN:SI:DOC-04QM1G3D/56154ad0-99f0-44f9-9bb7-ccbd01e95ecf/PDF"},"edm:rights":{"@rdf:resource":"http://rightsstatements.org/vocab/InC/1.0/"},"edm:provider":"Slovenian National E-content Aggregator","edm:intermediateProvider":{"@xml:lang":"en","#text":"National and University Library of Slovenia"},"edm:dataProvider":{"@xml:lang":"sl","#text":"Društvo Medicinski razgledi"},"edm:object":{"@rdf:resource":"http://www.dlib.si/streamdb/URN:NBN:SI:DOC-04QM1G3D/maxi/edm"},"edm:isShownAt":{"@rdf:resource":"http://www.dlib.si/details/URN:NBN:SI:DOC-04QM1G3D"}}}}